Gut microbes may partner with a protein to help regulate vitamin D

Microbes in the gut may use a protein in a process that helps the body regulate vitamin D production.

Using metabolomics to assess potential toxicity of plasticizers

The Omiecinski Lab collaborates with the Metabolomics Facility.

Studying rare genetic mutations with metabolomics

The Hanna-Rose Lab’s collaboration with the Metabolomics Facility yields new discoveries, projects, and funding.

Receptor may be key to treating nonalcoholic fatty liver disease

Receptor may be key to treating nonalcoholic fatty liver disease

Inhibiting a nuclear receptor in the gut could lead to a treatment for a liver disorder that affects almost 30 percent of the Western world's adult population, according to an international team of researchers.

World's cocoa crop could get a big boost from a simple, non-toxic spray

Huck scientists find Theobroma cacao trees' natural disease defense is bolstered by glycerol foliar treatment

Announcing major equipment acquisitions at the Huck Institutes

The Huck Institutes of the Life Sciences, in conjunction with the Office of the Vice President for Research and the Office of the Provost, are pleased to announce several major equipment acquisitions that will further strengthen the research capabilities of their Core Facilities at University Park.

Ancient gene family linked to the future of epileptic seizures

A potassium-channel gene belonging to an ancient gene family more than 542 million years old is opening new avenues in epilepsy research, and may one day allow researchers to develop more effective drugs with fewer side effects for the treatment of epileptic seizures.